Guobing� Li

1.8k total citations
47 papers, 1.4k citations indexed

About

Guobing� Li is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Guobing� Li has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Organic Chemistry. Recurrent topics in Guobing� Li's work include Autophagy in Disease and Therapy (7 papers), Mitochondrial Function and Pathology (6 papers) and Cell death mechanisms and regulation (4 papers). Guobing� Li is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Mitochondrial Function and Pathology (6 papers) and Cell death mechanisms and regulation (4 papers). Guobing� Li collaborates with scholars based in China, United States and Singapore. Guobing� Li's co-authors include Rong Zhang, Ning Gao, Xiaoye Hu, Changpeng� Hu, Jingbin� Huang, Wuyi Liu, Qian Zhang, Jing Zhou, Han‐Ming Shen and Wenjing Lai and has published in prestigious journals such as Oncogene, The FASEB Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Guobing� Li

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guobing� Li China 23 805 220 205 121 115 47 1.4k
Si Chen China 26 952 1.2× 185 0.8× 215 1.0× 219 1.8× 128 1.1× 83 2.0k
Lijun Zhang China 22 722 0.9× 150 0.7× 178 0.9× 194 1.6× 117 1.0× 63 1.4k
Manish Jain India 26 501 0.6× 215 1.0× 181 0.9× 109 0.9× 110 1.0× 104 1.8k
Yan Xiao China 24 1.1k 1.3× 167 0.8× 183 0.9× 105 0.9× 55 0.5× 61 1.8k
Hui Fu China 18 629 0.8× 126 0.6× 224 1.1× 168 1.4× 87 0.8× 66 1.2k
Tianxin Yang China 21 671 0.8× 141 0.6× 120 0.6× 170 1.4× 132 1.1× 30 1.2k
Zhixu He China 22 833 1.0× 145 0.7× 254 1.2× 305 2.5× 190 1.7× 52 1.6k
Eduardo Cremonese Filippi‐Chiela Brazil 20 920 1.1× 490 2.2× 225 1.1× 237 2.0× 97 0.8× 59 1.8k
Weitao Cong China 24 1.0k 1.3× 233 1.1× 179 0.9× 77 0.6× 52 0.5× 79 1.8k

Countries citing papers authored by Guobing� Li

Since Specialization
Citations

This map shows the geographic impact of Guobing� Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobing� Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobing� Li more than expected).

Fields of papers citing papers by Guobing� Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobing� Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobing� Li. The network helps show where Guobing� Li may publish in the future.

Co-authorship network of co-authors of Guobing� Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guobing� Li. A scholar is included among the top collaborators of Guobing� Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobing� Li. Guobing� Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Changpeng�, Huyue Zhou, Wuyi Liu, et al.. (2025). L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling. Neoplasia. 64. 101160–101160.
2.
Hu, Changpeng�, Ming Qin, Wenjing Lai, et al.. (2025). Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression. Journal for ImmunoTherapy of Cancer. 13(11). e012586–e012586.
3.
Cheng, Qu, et al.. (2025). Analysis on Taste Quality and Physicochemical Properties of Black Rice With Similar Apparent Amylose Content. Starch - Stärke. 77(5). 1 indexed citations
4.
Wang, Lingling, Wuyi Liu, Huyue Zhou, et al.. (2024). Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma. Neoplasia. 48. 100966–100966. 3 indexed citations
5.
Wang, Fumin, Qiang Yang, Qi Shen, et al.. (2024). Mechanistic insights on the preparation of 5-methyl-2-hexanone by hydrogenation of 5-methyl-3-hexen-2-one using Pd/Al2O3 catalysts. Journal of Colloid and Interface Science. 677(Pt A). 895–908.
6.
Liu, Wuyi, Huyue Zhou, Wenjing Lai, et al.. (2024). The immunosuppressive landscape in tumor microenvironment. Immunologic Research. 72(4). 566–582. 12 indexed citations
7.
Liu, Wuyi, Huyue Zhou, Wenjing Lai, et al.. (2024). Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1. Cell Communication and Signaling. 22(1). 378–378. 14 indexed citations
8.
Zhou, Min, Wenjing Lai, Rufu Xu, et al.. (2023). A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment. EBioMedicine. 94. 104724–104724. 18 indexed citations
9.
Liu, Yali, Wuyi Liu, Guobing� Li, et al.. (2023). Cu2−x Se nanoparticles suppress cell proliferation and migration in hepatocellular carcinoma by impairing mitochondrial respiration. Biomedical Materials. 18(3). 35013–35013.
10.
Wang, Zheng, Guobing� Li, Yan Xu, et al.. (2022). Solvent Effect on Product Distribution in the Aerobic Autoxidation of 2-Ethylhexanal: Critical Role of Polarity. Frontiers in Chemistry. 10. 855843–855843. 5 indexed citations
11.
Zhou, Min, Guobing� Li, Dandan Xie, et al.. (2022). Expandable carboxymethyl chitosan/cellulose nanofiber composite sponge for traumatic hemostasis. Carbohydrate Polymers. 294. 119805–119805. 57 indexed citations
12.
Zheng, Xiaoyuan, Shiming Yang, Rong Zhang, et al.. (2019). <p>Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes</p>. Drug Design Development and Therapy. Volume 13. 3171–3180. 52 indexed citations
13.
Li, Guobing�, Hongwei Zhang, Ruoqiu Fu, et al.. (2018). Mitochondrial fission and mitophagy depend on cofilin-mediated actin depolymerization activity at the mitochondrial fission site. Oncogene. 37(11). 1485–1502. 52 indexed citations
14.
Zhou, Li, Fan Yang, Guobing� Li, et al.. (2018). Coptisine Induces Apoptosis in Human Hepatoma Cells Through Activating 67-kDa Laminin Receptor/cGMP Signaling. Frontiers in Pharmacology. 9. 517–517. 33 indexed citations
15.
Xiao, Yue, et al.. (2017). Kinetics study and process simulation of transesterification of ethylene glycol with methyl acetate for ethylene glycol diacetate. The Canadian Journal of Chemical Engineering. 96(3). 722–730. 8 indexed citations
16.
Li, Guobing�, Qi Cheng, Lei Liu, et al.. (2013). Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway. Cell Communication and Signaling. 11(1). 50–50. 52 indexed citations
17.
Zhou, Ting, Guobing� Li, Bo Cao, et al.. (2013). Downregulation of Mcl-1 through inhibition of translation contributes to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in human leukemia cells. Cell Death and Disease. 4(2). e515–e515. 54 indexed citations
18.
Li, Guobing�, Zhaoyu Jin, Lin Zhang, et al.. (2013). Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation. Cell Death and Disease. 4(12). e941–e941. 35 indexed citations
19.
Li, Guobing�, Kristy Miskimen, William Ka Fai Tse, et al.. (2010). Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Leukemia. 24(8). 1397–1405. 24 indexed citations
20.
Li, Guobing�. (2006). Clean Synthesis of 1,6-Dicarbamate Hexane. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026